Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Comment by narmacon Dec 13, 2021 1:16pm
125 Views
Post# 34225663

RE:RE:RE:RE:RE:CALGARY, Alberta, Dec. 13, 2021 (GLOBE NEWSWIRE)

RE:RE:RE:RE:RE:CALGARY, Alberta, Dec. 13, 2021 (GLOBE NEWSWIRE) ,,,Dont worry,,there will be more delays told to us going forward,,,lots of carrot powder however.....what is not to expect but the rhetoric of past poor performance and their wishful thinking. This company is a disgrace,,,,,,a proverbial dog,,,,and not one thing will change this year or in 2022 except for the teams bank accounts. Shareholder value will never come close to what it could have been with experienced management. If a fellow can get out above a dollar I will slap myself patially silly and hope never to hear McCaffreys name again,,ever!!!,,,I for one am totally tired of his bovine excrement,,,,,the best news would be he is stepping down and attending to his mental health!!
<< Previous
Bullboard Posts
Next >>